Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8273 - 8280 of 12011 results
Hospitals Settle DOJ Suit Alleging Illegal Division of Marketing Territories
April 18, 2016| Blog| Viewpoint
Immigration Policy By Lottery? Another Year, Nothing Changes.
April 18, 2016| Blog| Viewpoint
Key Lessons from Patent Litigation for Drafting and Prosecuting Utility Patent Applications
April 15, 2016| Blog| Viewpoint
Data Center Development and Financing Strategies (AreaDevelopment)
April 15, 2016| Blog| Viewpoint
Zen Magnets Claims “90% Victory” Against CPSC in Magnet Recall Litigation
April 15, 2016| Blog| Viewpoint
Mintz's Health Care Enforcement Defense Group Publishes New Qui Tam Update
April 14, 2016| Blog| Viewpoint
Article 29 Working Party Opinions on Privacy Shield and Surveillance
April 14, 2016| Blog| Viewpoint
A Decade Later, Rules for the Sanitary Transportation of Food Finally Finalized by FDA
April 14, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|